ALNYLAM PHARMACEUTICALS INC
ALNYNASDAQ🏆 #357 by market capEarnings Oct 29Biotech
$221.20▲ $4.29 (+1.94%)
🌙 After hours$221.69▲ 0.22%Regular close · extended-hours price shown1h—
24h▲ 1.9%
7d▼ 3.3%
14d▼ 23.0%
30d▼ 23.2%
1y▼ 48.5%
🏦Market Cap
$29.53B
Mid Cap
📈Revenue Growth (YoY)
+95.1%
High Growth
📊Gross Margin
79.7%
High
💵FCF Margin
16.5%
Healthy
⚖️P/S Ratio
6.1x
Fair
Otter Score
63
Fair
Earnings
Q3 · 2026Reported 2026-07-30Earnings Per Share
Actual
1.21
Expected
1.63
miss
−25.80%
YoY +278.10%
Revenue
Actual
$1.29B
Expected
$1.32B
miss
−2.40%
YoY +66.90%
Consensus estimates
Recent quarters
Q3 2026
1.21
miss
Q2 2026
1.51
beat
Q1 2026
0.82
miss
Q4 2025
2.90
beat